{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:52:46Z","timestamp":1759960366713},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3542","type":"journal-article","created":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T22:05:52Z","timestamp":1433109952000},"page":"1421-1425","source":"Crossref","is-referenced-by-count":11,"title":["Methotrexate-associated Lymphoproliferative Disease with Multiple Pulmonary Nodules in a Patient with Rheumatoid Arthritis"],"prefix":"10.2169","volume":"54","author":[{"given":"Koichiro","family":"Suemori","sequence":"first","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ishizaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Ehime Prefectural University of Health Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuro","family":"Sugita","sequence":"additional","affiliation":[{"name":"Pathology Division, Ehime University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Yasukawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68: 1100-1104, 2009.","DOI":"10.1136\/ard.2008.093690"},{"key":"2","unstructured":"2. Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 1741-1743, 1991."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943-1949, 1996.","DOI":"10.1200\/JCO.1996.14.6.1943"},{"key":"4","unstructured":"4. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rizzi R, Curci P, Delia M, et al. Spontaneous remission of \"methotrexate-associated lymphoproliferative disorders\" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26: 1-9, 2009.","DOI":"10.1007\/s12032-008-9069-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cottin V, Tébib J, Massonnet B, Souquet PJ, Bernard JP. Pulmonary function in patients receiving long-term low-dose methotrexate. Chest 109: 933-938, 1996.","DOI":"10.1378\/chest.109.4.933"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shidara K, Hoshi D, Inoue E, et al. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol 20: 280-286, 2010.","DOI":"10.3109\/s10165-010-0280-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koji H, Yazawa T, Nakabayashi K, Fujioka Y, Kamma H, Yamada A. CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment. Mod Rheumatol 2014 [Epub ahead of print].","DOI":"10.3109\/14397595.2013.850613"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kudoh M, Harada H, Matsumoto K, Sato Y, Omura K, Ishii Y. Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol 118: 105-110, 2014.","DOI":"10.1016\/j.oooo.2014.02.029"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hansen A, Lipsky PE, Dörner T. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 3: 561-569, 2007.","DOI":"10.1038\/ncprheum0620"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang SS, Cozen W, Cerhan JR, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 67: 5042-5054, 2007.","DOI":"10.1158\/0008-5472.CAN-06-4752"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hoshida Y, Tomita Y, Zhiming D, et al. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 108: 443-449, 2004.","DOI":"10.1002\/ijc.11582"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wagner-Johnston ND, Ambinder RF. Epstein-Barr virus-related lymphoproliferative disorders. Curr Hematol Malig Rep 4: 249-254, 2007.","DOI":"10.1007\/s11899-007-0034-y"},{"key":"14","unstructured":"14. Starkebaum G. Rheumatoid arthritis and lymphoma: risky business for B cells. J Rheumatol 34: 243-246, 2007."},{"key":"15","unstructured":"15. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France, 2008: 350-351."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Feng WH, Cohen JI, Fischer S, et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96: 1691-1702, 2004.","DOI":"10.1093\/jnci\/djh313"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fanaian NK, Cohen C, Waldrop S, Wang J, Shehata BM. Epstein-Barr virus (EBV)-encoded RNA: automated in-situ hybridization (ISH) compared with manual ISH and immunohistochemistry for detection of EBV in pediatric lymphoproliferative disorders. Pediatr Dev Pathol 12: 195-199, 2009.","DOI":"10.2350\/07-07-0316.1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Loughrey M, Trivett M, Lade S, Murray W, Turner H, Waring P. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation. Pathology 36: 301-308, 2004.","DOI":"10.1080\/0031302042000224584"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kojima M, Itoh H, Hirabayashi K, et al. Methotrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. Pathol Res Pract 202: 679-685, 2006.","DOI":"10.1016\/j.prp.2006.05.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hare SS, Souza CA, Bain G, et al. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol 85: 848-864, 2012.","DOI":"10.1259\/bjr\/16420165"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91: 20-28, 2013.","DOI":"10.1111\/ejh.12116"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tokuhira M, Watanabe R, Nemoto T, et al. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma 53: 616-623, 2012.","DOI":"10.3109\/10428194.2011.625101"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:43:17Z","timestamp":1498221797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/11\/54_54.3542\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3542","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}